Description
Zylopen 875/125 mg is a combination antibiotic tablet manufactured by Radiant Pharmaceuticals Ltd. It contains 875 mg of Amoxicillin and 125 mg of Clavulanic Acid. Amoxicillin is a broad-spectrum penicillin-type antibiotic that inhibits bacterial cell wall synthesis, leading to bacterial cell death. Clavulanic Acid is a beta-lactamase inhibitor that protects Amoxicillin from degradation by beta-lactamase enzymes produced by certain bacteria, thereby enhancing its effectiveness against resistant strains. This combination is used to treat a variety of bacterial infections, including upper and lower respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, and intra-abdominal infections. Zylopen 875/125 mg is available in tablet form and is typically taken at the start of a meal to improve absorption and reduce gastrointestinal side effects. It is important to use this medication under the guidance of a healthcare provider to ensure its appropriateness and to minimize the risk of antibiotic resistance.
 2GM.jpeg)
 25MG.jpeg)
 ..jpeg)
 ..jpeg)
 1GM.jpeg)
.jpeg)
 10MG.jpeg)
 20MG.jpeg)
60 MG.jpeg)
Change Language